Electrophoresis Reagents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

The Electrophoresis Reagents Market is expected to register a CAGR of 5.11% during the forecast period.

Globally, the outbreak of COVID-19 was an incomparable public health emergency that affected the healthcare industry. The pandemic has had a notable impact on the market growth as electrophoresis techniques were used to develop effective therapies to separate DNA, RNA, or protein molecules based on their size for effective therapies against COVID-19. For instance, as per the National Clinical Trial (NCT) Registry updated in July 2022, Elsan conducted a clinical trial to assess serum inflammation profiles by protein electrophoresis on patients hospitalized for infection due to the SARS-CoV-2 virus. Such increasing research and development activities in developing effective therapies were expected to increase the demand for electrophoresis reagents during the COVID-19 pandemic. In addition, gel electrophoresis with other diagnostic technology was used to detect COVID-19. According to the study published in NCBI in November 2021, applying conventional PCR in conjunction with gel-electrophoresis for testing analysis is a possible approach for making SARS-CoV-2 diagnostics available worldwide. As a result, during the COVID-19 pandemic, the need for coronavirus disease diagnosis increased. This trend is expected to continue during the forecast period owing to the emergence of multiple variants, propelling the market growth.

The major factors driving the electrophoresis reagents market include the increasing funding for genomic and proteomic research; the rising prevalence of chronic diseases; increasing collaborations between industry and academia; and technological developments. According to the World Health Organization factsheet published in February 2022, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States. The report also mentioned that each year, approximately 400,000 children develop cancer globally. Cervical cancer is the most common in 23 countries, such as Eswatini, India, South Africa, Latin America, and others. The most common cancers are breast, lung, colon and rectum, and prostate cancers.

Additionally, for instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, in Asia and Australia 310 million. As the prevalence of chronic diseases increases, researchers continue to focus on providing prospective treatment options through research and development, which raises the need for gel electrophoresis, and electrophoresis reagents, consequently promoting the market’s growth.

Additionally, technological advancement in electrophoresis instruments further propels the market's growth. For instance, in September 2021, a novel capillary electrophoresis system, BioPhase8800, was introduced by Sciex Company for biological characterization during biopharmaceutical therapy. The new device analyses eight samples simultaneously and is a multi-capillary system for Capillary Electrophoresis Sodium Dodecyl Sulfate (CE-SDS).

Therefore, factors like increasing funding for genomic and proteomic research, the rising prevalence of chronic diseases, and technological developments are expected to promote the growth of the electrophoresis reagents market over the forecast period. However, time-consuming operations and the availability of other alternatives may restrain the market's growth over the forecast period.

Electrophoresis Reagents Market Trends

Gel Electrophoresis Segment is Expected to Hold a Major Market Share Over the Forecast Period

The major factors driving the gel electrophoresis segment include low operating and instrument costs, rising applications in the pharmaceutical and biotechnology industries, and the increasing burden of infectious diseases, cancer, and genetic disorders. For instance, as per the National Breast Cancer Foundation Inc., data published in June 2022 mentioned that by 2022, an estimated 287,500 new cases of invasive breast cancer is expected to be diagnosed in women in the United States and as well as 51,400 new cases of non-invasive breast cancer. The report also mentioned that an estimated 2,170 men are diagnosed with breast cancer in 2022 in the United States. Additionally, the MDPI article in July 2022 mentioned that 45.4% of breast cancer cases are diagnosed in Asian countries. Such a high prevalence of cancer across various regions worldwide is expected to drive the demand for effective research and developments for the production of appropriate therapeutics and diagnostics, thereby ultimately boosting the growth of the studied segment.

According to the study published in the PLOS ONE Journal in May 2022, a gel electrophoresis technique was used to identify many proteins that are significant for improved characterization of tumor progression and molecular specificity of both lung cancer subtypes. As a result of gel electrophoresis, it is possible to distinguish proteins from tumor cells, which aids in tumor diagnosis and may contribute to the segment's growth.

The growing technological advancement and product launches by the market players are expected to boost the market segment’s growth further. For instance, in September 2022, miniPCR bio, a developer of scientific equipment for researchers, unveiled the BanditTM STEM Electrophoresis Kit, an educational electrophoresis device. Bandit is a low-cost STEM activity kit that allows kids to build and operate a functioning gel electrophoresis device. Thus, the launches of innovative gel electrophoresis reagents by key market players are expected to contribute to the growth of the studied segment.

North America is Expected to Hold a Notable Market Share in the Electrophoresis Reagents Market

North America is expected to hold a significant market share over the forecast period. The major factors driving the market growth in North America include the increasing number of genomic research projects; the growing prevalence of chronic diseases; collaborations between industry and academia; cumulative research and development expenditure; the presence of a large number of major players; product launches; and technological advancements. The prevalence of cancer and infectious diseases is expected to drive market growth. For instance, according to the American Cancer Society Inc., data published in 2022, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States. In addition, according to the Public Health Agency of Canada data published in October 2021, approximately 2 in 5 Canadians were diagnosed with Cancer in their lifetime. In 2021, an estimated 229,000 Canadians were diagnosed with Cancer. The report also mentioned that lung, breast, colorectal, and prostate cancers were expected to remain the most commonly diagnosed cancers, accounting for nearly 46% of all cancer diagnoses in 2021. Likewise, the CDC updated in September 2021 reported that approximately 6.5 million people aged 40 and older in the United States have the peripheral arterial disease. Also, as per the February 2022 report from the Heart and Stroke Foundation of Canada, 750,000 people are living with heart failure, and 100,000 people are diagnosed with heart failure each year in Canada. Such a high prevalence of chronic disorders leading to driving demand for the development of effective therapeutics and diagnostics in North American countries is expected to contribute to the growth of the market.

Additionally, the launch of innovative products to meet the growing demand for effective therapeutics and diagnostics is also expected to contribute to the growth of the market in this region. For instance, in October 2021, Promega launched Sanger Sequencing Chemistry compatible, ProDye terminator sequencing reagent brings to any size laboratory. This can be implemented on any CE instrument, including the benchtop spectrum compact CE system.

Thus, the above-mentioned factors, such as rising chronic disorders, technological advancements, increasing product launches, and the presence of major market players, are expected to contribute to the market's growth in this region.

Electrophoresis Reagents Market Competitor Analysis

The Electrophoresis Reagents Market is moderately fragmented and competitive. The major players are found to adopt various strategies, such as agreements, expansion, contracts, partnerships, new reagent developments, joint ventures, and mergers and acquisitions, to strengthen their positions in the market. Some of the companies currently dominating the market are Agilent Technologies Inc., BioAtlas, Bio-Rad Laboratories Inc., Cytiva, Lonza Group AG, Merck KGaA, Qiagen NV, Sigma-Aldrich Corporation, Takara Bio Inc., and Thermo Fisher Scientific, among others.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.